FAKTOR-OPTIONSSCHEIN - AMGEN | Market Closed - Boerse Frankfurt Warrants 20:51:30 25/06/2024 BST | ||
| 2.21 EUR | +5.74% |
|
| Current month | +27.33% | ||
| 1 month | +22.35% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 25/06/24 | 2.19 | +4.78% |
| 24/06/24 | 2.09 | +11.76% |
| 21/06/24 | 1.87 | +1.63% |
| 20/06/24 | 1.84 | +8.24% |
| 19/06/24 | 1.7 | 0.00% |
Real-time Boerse Frankfurt Warrants
Last update June 25, 2024 at 08:51 pm
More quotesStatic data
| Product type | Produits Exotiques |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | 
Société Générale
|
| WKN | SB01UZ |
| ISIN | DE000SB01UZ8 |
| Date issued | 09/06/2020 |
| Strike | 225.4 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 8.83 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 19.24 € |
|---|---|
| Lowest since issue | 0.59 € |
| Spread | 0.03 € |
| Spread % | 1.36% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
319.3
USD
Average target price
316.4
USD
Spread / Average Target
-0.90%
- Stock Market
- Certificates
- Certificat
